Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Continuous IV cefuroxime preferable in patients with pneumonia

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Continuous IV cefuroxime preferable in patients with pneumonia. Pharmacoecon. Outcomes News 196, 10 (1999). https://doi.org/10.1007/BF03274794

    Download citation

    Keywords

    • Pneumonia
    • Health Outcome
    • Health Economic
    • Therapy Group
    • International Research